← Evidence map

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2020

Exon 16-Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M-Positive Non-Small Cell Lung Cancer.

Chia-Chi Hsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

55 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31557536